NewslettersPulmonary Cell NewsWhat Does Radiomics Do in PD-L1 Blockade Therapy of NSCLC Patients?By Bob - September 1, 20220245To explore the feasibility of the clinical application of radiomics in predicting PD-L1 expression, immunotherapy response, and long-term prognosis, the authors review and summarize recently published works in NSCLC.[Thoracic Cancer]Full Article